(Press-News.org)
The American Cancer Society estimates that more than 313,780 cases of prostate cancer will be diagnosed in the United States in 2025, resulting in approximately 35,770 deaths. Bone metastasis — a stage of prostate cancer where the disease spreads to the bones — is the leading cause of prostate cancer-related death and currently remains incurable.
“This stage of prostate cancer is devastating to the patient, as it often affects the bones of the spine, resulting in severe pain from fractures and spinal cord compression, along with significant neurological and functional disabilities,” Srinivas Nandana, Ph.D., said. “The current treatment for this advanced stage of the disease is limited to palliative care aimed at relieving symptoms, with no real hope of reducing or limiting the progression of the disease itself.”
With support from a three-year, $1.85 million grant from the U.S. Department of Defense (DoD) (“Role of TBX2 in the establishment of the Prostate Cancer Pre-Metastatic Niche (PMN) in the Bone”), Nandana and co-investigator Manisha Tripathi, Ph.D., from the Department of Cell Biology and Biochemistry at the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine will investigate the role of TBX2, a transcription factor, in establishing the prostate cancer premetastatic niche in bone. Their research seeks to advance the understanding of prostate cancer metastasis and develop novel treatment strategies.
Nandana’s laboratory has focused on deciphering the role of TBX2 in prostate cancer for more than a decade, supported primarily by grants from the DoD, the Cancer Prevention Research Institute of Texas-Texas Regional Excellence in Cancer, the Ted Nash Long Life Foundation and The CH Foundation. Building on findings from their previous study published in Cancer Research (“Bone Metastasis of Prostate Cancer Can be Therapeutically Targeted at the TBX2-WNT Signaling Axis”) and new data, Nandana and Tripathi will investigate the earliest stages of the bone metastasis process.
During these stages, the primary prostate tumor continually releases tiny sac-like membrane structures called exosomes, which contain proteins and RNA molecules. These exosomes travel through the bloodstream and interact with normal bone cells. Once in the bone, they share their molecular contents, causing the bone cells to “remodel” into a potential future “nesting” site, or “pre-metastatic niche,” making the bone more hospitable to arriving cancer cells.
At some point, Nandana said, a circulating cancer cell homes in on one of these bone nesting sites and then grows, divides and becomes a new metastatic tumor mass.
“We believe a specific molecular pathway — the TBX2-NOTCH axis — plays a key role in preparing bones to host these cancer cells,” Nandana explained. “Our goal is to test ways to block or disrupt this pathway. By doing so, we hope to significantly reduce, or even prevent, the ability of prostate cancer to spread to the bones. We also believe that, driven by TBX2 signaling, the exosomal transport of the NOTCH intracellular domain 3 (NICD3) protein to bone cells is the critical step in the entire bone remodeling, pre-metastatic niche creation process.”
Nandana said a more complete understanding of this early exosome-mediated communication system between the primary prostate tumor and bone may open up new avenues to intervene and disrupt the process, potentially slowing or even preventing bone metastasis.
In their upcoming studies, Nandana and Tripathi will combine the use of laboratory and mouse models of human prostate cancer with genetic techniques to study the NICD3 protein. Their aim is to determine whether the NICD3 protein, secreted in exosomes due to elevated TBX2 in tumor cells, is essential for creating the bone environment that enables metastatic prostate cancer cells to establish and grow.
“We will also evaluate whether an existing class of anticancer drugs, known as gamma secretase inhibitors (GSIs), can reduce NICD3 formation in primary tumor cells to levels insufficient to initiate the bone remodeling and metastatic process, thereby reducing or potentially preventing prostate cancer bone metastases,” Nandana said. “GSIs are clinically-approved agents, so if successful, direct clinical testing could proceed rapidly.”
If the research proves successful, Nandana said it could lead to new treatment approaches aimed at slowing or preventing prostate cancer bone metastasis, a significant advancement considering that bone metastases are currently incurable and often result in intense pain, fractures and loss of mobility. Stopping metastasis before it begins could significantly improve outcomes and quality of life for patients.
As part of the study, Nandana and Tripathi also will assess drugs already approved for other conditions. If any of these drugs show promise, they could potentially be repurposed for prostate cancer treatment more quickly than newly developed therapies.
“While this research is still in its early stages, it offers promising new insights into how prostate cancer spreads and how we might intervene earlier in that process,” Nandana said. “Bone metastasis causes serious problems for patients, including pain and reduced mobility. If we can better understand how cancer interacts with bone in the early stages, we might be able to reduce the impact of advanced disease. This could help improve comfort and quality of life for some patients, and potentially delay or prevent complications related to bone metastases.”
###
END
Scientists with the Fralin Biomedical Research Institute at VTC have created an engineered model of the supportive tissue found within a lymph node to study human health.
Working with scientists at the University of Virginia, the researchers are building a bioengineered model of a human lymph node, which performs essential roles in the immune system throughout the body.
The goal of the research, which published in April in APL Bioengineering, is to provide scientists with a model that accurately mirrors dynamic fluid flow — a natural part of how lymph nodes ...
The MIT Press is proud to announce that it will be adding Goldsmiths Press books to its open access platform, Direct to Open (D2O), starting in 2026. The partnership expands the offerings freely available through D2O, and furthers both press’ missions in building a more open and accessible future for academic publishing.
Launched in 2021, D2O is the MIT Press’s bold, innovative framework for open access monographs that shifts publishing from a solely market-based purchase model where individuals and libraries buy single ...
Getting used to carbon monoxide
T. kivui grows at high temperatures and is able to produce organic substances from simple molecules such as carbon dioxide and hydrogen. These properties can be used to utilize the bacterium in connection with biomass gasification plants, for example, in order to valorlize synthesis gas produced there from waste biomass such as agricultural residues or wood waste. For example, T. kivui can be used to sustainably produce acetic acid through gas fermentation and, after appropriate genetic modification, ethanol or isopropanol – raw materials ...
The architecture and processes underlying visual word recognition represent some of the most intricate systems in human cognition. The seemingly simple act of reading a word involves not only a complex interplay between cognitive layers but also relationships between the word’s spelling, phonology, and meaning. Over time, research has revealed that our mental systems rely on specific, consistent mappings between these properties to perform fast and accurate word recognition.
In particular, multiple studies have shown that orthographic-semantic ...
Since the time of the ancient Greek physician Hippocrates, cancer has been recognized as being sensitive to heat. Today, this principle forms the basis of hyperthermia treatment—a promising cancer therapy that uses controlled heat to kill tumor cells while sparing healthy ones. Unlike chemotherapy or radiation, hyperthermia works by heating cancerous tissue to temperatures around 50 °C, causing cancer cell death while simultaneously activating the body's immune system against the tumor. This approach holds particular ...
Hyponatremia, or low blood sodium concentration, is typically viewed as a symptomless condition—until recently. A research team led by Professor Yoshihisa Sugimura, including Dr. Haruki Fujisawa, Professor Atsushi Suzuki, Professor Tsuyoshi Miyakawa, and Professor Akihiro Mouri, from Fujita Health University, Japan, has demonstrated that chronic hyponatremia (CHN) can directly cause anxiety-like behaviors in mice by disrupting key neurotransmitters in the brain. Their findings, published online in the journal Molecular Neurobiology on May 14, 2025, reveal that CHN alters monoaminergic signaling in the amygdala, a brain region ...
To reduce greenhouse gas emissions and combat climate change, the world urgently needs clean and renewable energy sources. Hydrogen is one such clean energy source that has zero carbon content and stores much more energy by weight than gasoline. One promising method to produce hydrogen is electrochemical water-splitting, a process that uses electricity to break down water into hydrogen and oxygen. In combination with renewable energy sources, this method offers a sustainable way to produce hydrogen and can contribute ...
A rich and varied mix of microbes in the mouth, particularly bacteria, is not only important for our oral health, but may hold clues for other conditions. A new study led by researchers at NYU Rory Meyers College of Nursing finds that a lower diversity of microbes in the mouth is associated with depression.
The mouth is home to between 500 billion and 1 trillion bacteria—the second-largest community of microorganisms in our bodies, after the gut. A growing number of studies point to the connection between the oral microbiome and our overall health, from diabetes to dementia, a relationship thought to be driven by inflammation and disruptions to the immune system.
A recent ...
“China virus”, the Chinese virus — at the start of the 2020 pandemic, you likely often encountered this epithet in the media. The use of geographically-based labels to define the disease (COVID-19) and the virus causing it (SARS-CoV-2) had significant consequences on public opinion, fueling and amplifying — sometimes with very serious outcomes — prejudices against specific people and countries, accused of having a causal role in spreading the contagion. The neutral designation COVID-19, proposed for the disease by the WHO in mid-February 2020, was quickly adopted globally. However, ...
Thanks to lab-grown miniature intestines, researchers at Uppsala University have successfully mapped how aggressive Shigella bacteria infect the human gut. The study opens the door to using cultured human mini-organs to investigate a wide range of other serious infections.
Understanding how human-specific bacteria make us sick is challenging, as laboratory animals rarely reflect human physiology. In a new study published in Nature Genetics, researchers show that it is now possible to use cultured mini-organs to map how bacteria colonise the human intestinal mucosa. The team focused specifically on Shigella, a bacterium that causes severe ...
